Patents by Inventor Theonie Anastassiadis

Theonie Anastassiadis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230203510
    Abstract: The disclosure relates generally to methods of modulating a production parameter of an RNA corresponding to, or polypeptide encoded by, a nucleic acid sequence comprising an endogenous ORF having a premature termination codon, comprising administering a tRNA-based effector molecule having a non-naturally occurring modification.
    Type: Application
    Filed: May 28, 2021
    Publication date: June 29, 2023
    Inventors: Theonie Anastassiadis, David Charles Donnell Butler, Neil Kubica, Qingyi Li
  • Publication number: 20230203509
    Abstract: The disclosure relates generally to uses of tRNA-based effector molecules having a non-naturally occurring modification.
    Type: Application
    Filed: May 28, 2021
    Publication date: June 29, 2023
    Inventors: Theonie Anastassiadis, David Arthur Berry, Christine Elizabeth Hajdin, Noubar Boghos Afeyan, David Charles Donnell Butler, Qingyi Li
  • Publication number: 20230054178
    Abstract: The invention relates generally to tRNA-based effector molecules having a non-naturally occurring modification and methods relating thereto.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 23, 2023
    Inventors: Theonie Anastassiadis, David Charles Donnell Butler, Neil Kubica, Qingyi Li
  • Publication number: 20220364092
    Abstract: The invention relates generally to uses of tRNA-based effector molecules (TREMs) corresponding to con-rare codons and methods of making the same.
    Type: Application
    Filed: November 4, 2020
    Publication date: November 17, 2022
    Inventors: Christine Elizabeth Hajdin, David Arthur Berry, Theonie Anastassiadis, Noubar Boghos Afeyan
  • Publication number: 20220364075
    Abstract: The disclosure relates generally to methods of modifying a nucleic acid sequence, systems for modifying a nucleic acid sequence, and compositions made by said methods or systems.
    Type: Application
    Filed: November 4, 2020
    Publication date: November 17, 2022
    Inventors: Christine Elizabeth Hajdin, David Arthur Berry, Theonie Anastassiadis, Noubar Boghos Afeyan
  • Publication number: 20220228147
    Abstract: The invention relates generally to uses of tRNA-based effector molecules (TREMs) and methods of making the same.
    Type: Application
    Filed: May 29, 2020
    Publication date: July 21, 2022
    Inventors: David Arthur Berry, Theonie Anastassiadis, Christine Elizabeth Hajdin, Noubar Boghos Afeyan
  • Publication number: 20220112489
    Abstract: The invention relates generally to tRNA-based effector molecules and methods relating thereto.
    Type: Application
    Filed: January 17, 2020
    Publication date: April 14, 2022
    Inventors: David Arthur Berry, Theonie Anastassiadis, Noubar Boghos Afeyan, Christine Elizabeth Hajdin